Assessment of intelligence quotient in patients with neuromyelitis optica spectrum disease and multiple sclerosis.

[1]  Yanling Lang,et al.  Neuromyelitis optica spectrum disorder in Western China impacts employment and increases financial burden in women , 2022, Frontiers in Neurology.

[2]  M. Arsalidou,et al.  Quantitative Meta-analyses of Cognitive Abilities in Children With Pediatric-onset Multiple Sclerosis , 2022, Neuropsychology Review.

[3]  J. Fielding,et al.  Working Memory Phenotypes in Early Multiple Sclerosis: Appraisal of Phenotype Frequency, Progression and Test Sensitivity , 2022, Journal of clinical medicine.

[4]  C. E. Han,et al.  Disrupted structural network of inferomedial temporal regions in relapsing–remitting multiple sclerosis compared with neuromyelitis optica spectrum disorder , 2022, Scientific reports.

[5]  S. Dubey,et al.  A comparison of cognitive performances between neuromyelitis optica spectrum disorder and multiple sclerosis patients in Indian context , 2021, The Egyptian Journal of Neurology, Psychiatry and Neurosurgery.

[6]  M. Sahraian,et al.  The prevalence of cognitive impairment in patients with neuromyelitis optica spectrum disorders (NMOSD): A systematic review and meta-analysis. , 2021, Multiple sclerosis and related disorders.

[7]  F. Paul,et al.  Differences in Advanced Magnetic Resonance Imaging in MOG-IgG and AQP4-IgG Seropositive Neuromyelitis Optica Spectrum Disorders: A Comparative Study , 2020, Frontiers in Neurology.

[8]  Z. Pašić,et al.  Cognitive Disorders in Patients with Multiple Sclerosis , 2020, Materia socio-medica.

[9]  V. Shaygannejad,et al.  Comparison of sleep complaints and quality of life between patients with neuromyelitis optica spectrum disorder (NMOSD) and healthy controls. , 2019, Multiple sclerosis and related disorders.

[10]  V. Shaygannejad,et al.  Comparative study of quality of life, anxiety, depression, and fatigue among patients with neuromyelitis optica spectrum disorder and multiple sclerosis: The first report from Iran. , 2018, Multiple sclerosis and related disorders.

[11]  David H. Miller,et al.  Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria , 2017, The Lancet Neurology.

[12]  K. Fujihara,et al.  Cognitive impairment in neuromyelitis optica spectrum disorders: A comparison of the Wechsler Adult Intelligence Scale-III and the Wechsler Memory Scale Revised with the Rao Brief Repeatable Neuropsychological Battery , 2017, eNeurologicalSci.

[13]  N. Takahashi,et al.  Comparison of cognitive and brain grey matter volume profiles between multiple sclerosis and neuromyelitis optica spectrum disorder , 2017, PloS one.

[14]  Yuehai Shen,et al.  Cognitive dysfunction in adult patients with neuromyelitis optica: a systematic review and meta-analysis , 2017, Journal of Neurology.

[15]  Blanka Klimova,et al.  Cognitive decline in normal aging and its prevention: a review on non-pharmacological lifestyle strategies , 2017, Clinical interventions in aging.

[16]  K. Fujihara,et al.  Neuromyelitis Optica Spectrum Disorders. , 2017, Neuroimaging clinics of North America.

[17]  T. Riise,et al.  Preclinical disease activity in multiple sclerosis: A prospective study of cognitive performance prior to first symptom , 2016, Annals of neurology.

[18]  J. Joo,et al.  Cognitive impairment differs between neuromyelitis optica spectrum disorder and multiple sclerosis , 2016, Multiple sclerosis.

[19]  A. Methley,et al.  Cognitive and psychiatric comorbidities in neuromyelitis optica , 2016, Journal of the Neurological Sciences.

[20]  Y. Liu,et al.  Cognitive impairment in Chinese neuromyelitis optica , 2015, Multiple sclerosis.

[21]  Chunshui Yu,et al.  Structural MRI substrates of cognitive impairment in neuromyelitis optica , 2015, Neurology.

[22]  Martin Voracek,et al.  Meta-analysis of associations between human brain volume and intelligence differences: How strong are they and what do they mean? , 2015, Neuroscience & Biobehavioral Reviews.

[23]  A. Traboulsee,et al.  International consensus diagnostic criteria for neuromyelitis optica spectrum disorders , 2015, Neurology.

[24]  Terry J. Smith,et al.  Use of Advanced Magnetic Resonance Imaging Techniques in Neuromyelitis Optica Spectrum Disorder. , 2015, JAMA neurology.

[25]  V. Sinay,et al.  School performance as a marker of cognitive decline prior to diagnosis of multiple sclerosis , 2015, Multiple sclerosis.

[26]  F. Paul,et al.  MRI characteristics of neuromyelitis optica spectrum disorder , 2015, Neurology.

[27]  J. Fletcher,et al.  The Flynn effect: a meta-analysis. , 2014, Psychological bulletin.

[28]  Christian Enzinger,et al.  Higher Education Moderates the Effect of T2 Lesion Load and Third Ventricle Width on Cognition in Multiple Sclerosis , 2014, PloS one.

[29]  J. DeLuca,et al.  Brain reserve and cognitive reserve in multiple sclerosis , 2013, Neurology.

[30]  R. Rey,et al.  Cognitive performance of neuromyelitis optica patients: comparison with multiple sclerosis. , 2013, Arquivos de neuro-psiquiatria.

[31]  J. Armspach,et al.  White matter volume is decreased in the brain of patients with neuromyelitis optica , 2013, European journal of neurology.

[32]  M. Otsuki,et al.  Cognitive impairment and cortical degeneration in neuromyelitis optica , 2013, Annals of neurology.

[33]  D. Kreiner,et al.  Wechsler Adult Intelligence Scale–Fourth Edition performance in relapsing–remitting multiple sclerosis , 2012, Journal of clinical and experimental neuropsychology.

[34]  L Penke,et al.  Brain white matter tract integrity as a neural foundation for general intelligence , 2012, Molecular Psychiatry.

[35]  A. Giorgio,et al.  Association of MRI metrics and cognitive impairment in radiologically isolated syndromes , 2012, Neurology.

[36]  Jeffrey A. Cohen,et al.  Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria , 2011, Annals of neurology.

[37]  Karrie A Shogren,et al.  Public policy and outcomes for persons with intellectual disability: extending and expanding the public policy framework of AAIDD's 11th Edition of Intellectual Disability: Definition, Classification, and Systems of Support. , 2010, Intellectual and developmental disabilities.

[38]  I. Deary,et al.  Intelligence and education: causal perceptions drive analytic processes and therefore conclusions. , 2010, International journal of epidemiology.

[39]  J. DeLuca,et al.  Cognitive impairment in multiple sclerosis , 2008, The Lancet Neurology.

[40]  R Vecchio,et al.  Cognitive and psychosocial features of childhood and juvenile MS , 2008, Neurology.

[41]  Y. Itoyama,et al.  Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis. , 2007, Brain : a journal of neurology.

[42]  J. Parisi,et al.  Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis. , 2007, Brain : a journal of neurology.

[43]  B. Weinshenker,et al.  Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression. , 2006, Archives of neurology.

[44]  B. Weinshenker,et al.  Brain abnormalities in neuromyelitis optica. , 2006, Archives of neurology.

[45]  S. Reingold,et al.  Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria” , 2005, Annals of neurology.

[46]  A. Verkman,et al.  The Journal of Experimental Medicine CORRESPONDENCE , 2005 .

[47]  Ichiro Nakashima,et al.  A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis , 2004, The Lancet.

[48]  J. Kurtzke.  Rating neurologic impairment in multiple sclerosis , 1983, Neurology.

[49]  D. Reich,et al.  Multiple Sclerosis , 2018, The New England journal of medicine.

[50]  Frédéric Blanc,et al.  Cognitive functions in neuromyelitis optica. , 2008, Archives of neurology.